Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
  • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
  • A61M1/3621—Extra-corporeal blood circuits
  • A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods
  • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
  • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
  • A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
  • A61B17/12109—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
  • A61B17/00—Surgical instruments, devices or methods
  • A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
  • A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
  • A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
  • A61B17/12136—Balloons
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
  • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
  • A61M1/3613—Reperfusion, e.g. of the coronary vessels, e.g. retroperfusion
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
  • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
  • A61M1/3621—Extra-corporeal blood circuits
  • A61M1/3653—Interfaces between patient blood circulation and extra-corporal blood circuit
  • A61M1/3659—Cannulae pertaining to extracorporeal circulation
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
  • A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
  • A61M25/0026—Multi-lumen catheters with stationary elements
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/10—Balloon catheters
  • A61M25/1002—Balloon catheters characterised by balloon shape
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/10—Balloon catheters
  • A61M2025/1043—Balloon catheters with special features or adapted for special applications
  • A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/10—Balloon catheters
  • A61M2025/1043—Balloon catheters with special features or adapted for special applications
  • A61M2025/1097—Balloon catheters with special features or adapted for special applications with perfusion means for enabling blood circulation only while the balloon is in an inflated state, e.g. temporary by-pass within balloon
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
  • A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
  • A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked

Definitions

• the invention relates to a new arterial cannula that can be used for performing a regional extracorporeal circulation, used in particular for the removal of organs from donors who died after cardiac arrest (DDAC).
• DDAC cardiac arrest
• the Biomedicine Agency has published the kidney and liver collection procedure for this type of donor. This procedure involves the placement of femoral arterial and venous cannulas to restore normothermic circulation and a contralateral femoral arterial Fogarty tube, which is deployed and balloon positioned about 5 cm above the diaphragm. in order to regionalize extracorporeal circulation and thus avoid cardiac and cerebral reperfusions.
• the procedure provides that the circulatory assistance is started after positioning the Fogarty probe.
• This circulatory support must be operational 150 minutes after the occurrence of the cardiac arrest of the patient
• the average arrival time of DDAC potentials is 1 13 ⁇ 31 minutes (D.Barouk et al., Resuscitation 2010 (19) 1 S: SP 105).
• the introduction procedure of the Fogarty probe alone takes about 20 to 30 minutes. It is then necessary to introduce the two cannulas to set up the regionalized circulation, which takes about 20 to 30 additional minutes, in the absence of technical difficulties. Thus, from the beginning of the intervention, a minimum time of 40 minutes is necessary before being able to start taking the organs. At this stage of the procedure, an average of 153 minutes elapsed since the cardiac arrest, in the absence of technical difficulties of insertion of the cannulas.
• the invention thus relates to an arterial cannula, obliterated at its distal end, and which is provided with an occlusive balloon for regionalization of extracorporeal circulation.
• this cannula is multiperforated, which allows the perfusion of the organs to be removed (kidneys and liver).
• this cannula thus allows to install in a single step the element allowing the regionalization of the normothermic circulation, as well as the source of supply of oxygenated blood. This makes it possible to accelerate the setting up of pre-requisites before the removal of the organs, and consequently, to improve the physiological state of the grafts by decreasing the hot ischemia time, while decreasing the failure rate of current sampling due to the impossibility of respecting the deadlines set for the establishment of normothermic circulation. Finally, the use of this cannula avoids incision in the contralateral femoral artery in the potential donor, and increased respect for the integrity of the body.
• WO 99/37202 discloses a cannula for maintaining a blood circulation in a patient whose heart is stopped, an occluding member for obstructing the ascending aorta to maintain the regionalization of the circulation.
• This cannula is open at its distal end, and also has side ports located near the distal end of the cannula to allow blood flow if the end is obstructed by the occlusion member.
• WO 99/30766 discloses a cannula coupled to an occlusive element located at its distal end.
• This cannula may comprise three tubes (lumens or lumens), for a) injecting a cardioplegia solution, b) injecting a fluid to inflate the occlusive element and c) be used for aspiration.
• the solution provided may be delivered upstream or downstream of the occlusive element.
• No. 6,267,747 discloses cannulae having a balloon at their distal ends, as well as orifices located proximally to said balloon. These cannulas are intended for cardiac surgery (paragraph "Field of the invention”). They must allow the introduction of a cardioplegic fluid downstream of the occlusion element (column 2, lines 25-44).
• the cannulae of D2 have at least three lumens ( Figure 2).
• US 2005/171505 discloses three-channel cannulas. These cannulas are not occulted downstream of the occlusion element, having orifices (3) downstream of this element (abbreviated and FIG. 8).
• US 2003/229332 discloses a cannula which is more particularly intended to remove an element (such as a kidney stone).
• US 4,892,519 discloses a cannula having orifices downstream of the balloon.
• Figure 1 shows a side view of a cannula according to the invention. It comprises a proximal end (1) and a distal end (2), connected by a body (3) comprising a first hollow tube (1 1) whose proximal end (12) is open and the distal end ( 13), and a second hollow tube (21) whose proximal (22) and distal (23) ends are open, the distal end (23) of said tube (21) terminating within an element of occlusion (4) toric located near the distal end (2) of the cannula, said first hollow tube (1 1) having three orifices (14).
• the distal end (2) of the cannula has a rounded cone shape.
• Figure 2 shows top views of the cannula according to the invention.
• 2.A the two lights (1 1) and (21) are concentric.
• 2.B the light (21) is located on the edge of the body (3).
• FIG. 3 represents a cannula according to the invention, introduced into the aorta of a donor, via the right femoral artery. Renal arteries (31, 32) and the celiac trunk (33) are indicated. 4 orifices (14) located near the proximal end (2) are shown.
• Figure 4 shows a side view of another cannula according to the invention. It shows the proximal end (1) and the distal end (2), connected by the body (3) comprising a first hollow tube (1 1) whose proximal end (12) is open and the distal end (13) closed, and a second hollow tube (21) whose proximal (22) and distal (23) ends are open, the distal end (23) of said tube (21) terminating within a d occlusion (4) of cylindrical shape located near the distal end (2) of the cannula, said first hollow tube (1 1) having two orifices (14).
• the invention thus relates to a cannula for medical use, comprising a proximal end (1) and a distal end (2), connected by a body (3) comprising a first hollow tube (1 1) whose proximal end ( 12) is open and the distal end (13) closed, and a second hollow tube (21) whose proximal (22) and distal (23) ends are open, the distal end (23) of said tube (21) terminating inside an occlusion element (4) located near the distal end (2) of the cannula, said first hollow tube (1 1) presenting at least one orifice (14) close to the end distal (2) of the cannula located proximally to the occlusion member (4).
• the orifice (14) thus connects the lumen (1 1) to the outside of the cannula.
• light (lumen) may be used instead of the term “tube”.
• near the distal end or “near the distal end” refer to a distance of between 1 and 10 cm from the distal end (2).
• the cannula (realization of a regional extracorporeal circulation, for removal of organs from deceased donors after cardiac arrest (DDAC)) thus requires the presence of only two lights: a light to inflate the inclusion element and a light to help restore blood flow regionally. It is therefore clear that the cannula comprises only a light (1 1) and a light (21).
• the distal end (2) of the cannula is of half-spherical shape. More preferably, this distal end (2) has the shape of a cone whose tip is rounded. This shape of the distal end (2) and the fact that it is restricted and has a diameter smaller than the diameter of the body (3) of the cannula reduces the risk of damaging the arteries during the introduction. of the cannula.
• the occlusion element (4) can in particular be fixed on the cannula by a collar located at the end of the cannula. This occlusion element is preferably a balloon or balloon and may be designated as such in the present description. When contracted, it is associated against the outer surface of the body (3) of the cannula.
• the occlusion element (4) is inflated by sending a fluid into this element via the second lumen (21) of the cannula.
• a liquid solution such as physiological saline
• a liquid solution is preferably used.
• the balloon (4) is filled with foam and is contracted for insertion into the patient's body by applying a negative pressure or because it is covered with a sleeve.
• the balloon expands to obstruct the aorta when the sleeve is released or the negative pressure is stopped.
• This occlusion element may be spherical, conical, elliptical, toric or funnel-shaped.
• the inner surface of the occlusion member (4) is adjacent to the outer surface of the cannula body (3), the outer surface serving to obscure the aorta of the patient.
• this occlusion member (4) is placed approximately 2-3 cm before the distal end (2) of the cannula.
• the occlusion element is said to be "compilant”, that is to say it adapts to the diameter of the artery when inflated (even inflated to its maximum), without risk of damaging the wall of the artery. Its maximum diameter after inflation is less than 45 mm.
• a compiling balloon has the ability to deform to fit the diameter of the aorta, even inflated to the maximum.
• the diameter of the aorta of patients is of the order of 24 mm for women, and 24 to 27 mm for men.
• the cannula according to the invention is in particular intended to be introduced by the femoral artery of a patient, and inserted via the aorta until the occlusion element is located at the aortic orifice of the diaphragm.
• each of the lumens is thus advantageously provided with a tubular connecting socket for connecting the first lumen to a pump for the injection of oxygenated blood, and the second lumen for a pump or a syringe for inflation. or deflating the occlusion element.
• the first light (1 1) is thus intended to circulate oxygenated blood, introduced from the proximal end. It should be released into the arteries of the patient in order to continue to irrigate the organs of interest (liver and kidneys).
• the orifice (s) (14) allows (s) to provide a flow rate of about 4 liters / minute.
• the cannula has a plurality of orifices (14) distributed along the length of the first lumen (1 1). These orifices are preferably distributed all around the body (3), and are located at a distance of between 6 to 10 cm and 30 to 40 cm from the distal end (2) of the cannula.
• the orifices (14) for releasing the oxygenated blood introduced from the proximal end of the lumen (1 1) are all located proximally to the occlusion element (4). ). It is also clear that there can be no orifice (14) (connecting the lumen (1 1) to the outside of the cannula) located distally to the occlusion element (4), which would lead to a reperfusion of the superior organs (cardiac or cerebral).
• the inner diameter of the cannula is between 12 and 20 French (Fr).
• the French is the unit of measure of the diameter of the catheters, and corresponds to 0.33 mm.
• the diameter of the cannula is between 15 to 18 Fr.
• the surface of these orifices is equal to the surface of the cannula.
• the surface of the cannula is of the order of 20 mm 2 when the diameter of the cannula is 15 Fr.
• the total surface of the orifices (14) must be of this order.
• Another number of orifices (14) can be envisaged, their diameter being then easily calculated to meet the blood flow requirements to be maintained in the donor arteries.
• the two tubes (1 1) and (21) are concentric.
• the central tube (21) is used to circulate the fluid for inflation of the balloon, while the radial tube (1 1) is intended for blood circulation ( Figure 2.A).
• the second tube (21) is located on the periphery of the first tube (1 1), that is to say on an edge of the first tube, or directly inside the material constituting the body of the cannula (Figure 2.B).
• the diameter of the first lumen (1 1) is 4 to 5 times larger than the diameter of the second lumen (21).
• the cannula according to the invention must be inserted via the femoral artery of the patient to the level of the diaphragm. It is therefore envisaged that it has a length greater than or equal to 50 cm, preferably around 80 cm.
• the cannula according to the invention may be in any material suitable for medical use. It is preferably made of flexible plastic, non-thrombogenic, in order to easily pass through the arteries of the patient. It can thus be made of silicone, polyurethane, or polytetrafluoroethylene (known under the brand name Teflon®).
• the materials of manufacture of the occlusion element (4) are known in the art. This can be polyurethane.
• the cannula according to the invention can be sterilized by any means known in the art (such as the use of ethylene oxide, irradiation with beta or gamma rays), and packaged in packages that are opened during the operation.
• this cannula is used for the establishment of a regionalized external circulation, and is preferably used in an act related to the removal of an abdominal organ such as the liver or the kidneys, in particular on a DDAC .
• One of the advantages of the cannula according to the invention is the possibility of infusing the oxygenated blood higher in the body of the patient, and therefore closer to arteries to the organs of interest (celiac trunk to the liver, and renal arteries).
• the arterial cannula releases blood at the junction between the iliac artery and the aorta. He must therefore "go up” the aorta to enter the aforementioned arteries. Locating the orifices (14) directly under the occlusion device causes the blood to be released closer to these arteries. This can be an advantage for the quality of organs.
• the invention also relates to a method of removing an abdominal organ (liver, kidney) from a deceased donor after cardiac arrest, comprising the steps of
• the cannula into a femoral artery, this artery being easily accessible under the conditions of limited time available to the practitioner, but it can be introduced into another artery such as an external iliac artery. This is also valid for the venous cannula mentioned in step c).

Landscapes

• Health & Medical Sciences (AREA)
• Heart & Thoracic Surgery (AREA)
• Life Sciences & Earth Sciences (AREA)
• Vascular Medicine (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Engineering & Computer Science (AREA)
• Veterinary Medicine (AREA)
• Biomedical Technology (AREA)
• Public Health (AREA)
• Hematology (AREA)
• Anesthesiology (AREA)
• Surgery (AREA)
• Cardiology (AREA)
• Reproductive Health (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Medical Informatics (AREA)
• Molecular Biology (AREA)
• Biophysics (AREA)
• Pulmonology (AREA)
• Child & Adolescent Psychology (AREA)
• Media Introduction/Drainage Providing Device (AREA)
• External Artificial Organs (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=43530504

Family Applications (1)

Country Status (5)

Families Citing this family (6)

Citations (1)

Family Cites Families (9)

• 2010
  • 2010-06-23 FR FR1055029A patent/FR2961683B1/fr not_active Expired - Fee Related
• 2011
  • 2011-06-22 WO PCT/EP2011/060425 patent/WO2011161146A1/fr not_active Ceased
  • 2011-06-22 US US13/806,492 patent/US20130281926A1/en not_active Abandoned
  • 2011-06-22 EP EP11728240.0A patent/EP2584979A1/de not_active Withdrawn
  • 2011-06-22 CA CA2803230A patent/CA2803230C/fr not_active Expired - Fee Related

Patent Citations (1)

Also Published As

Similar Documents

Legal Events